# L&C Bio develops fat injection to treat ‘Ozempic face’ 2026-08-08T20:50:45+00:00 | Health & Science | Indian Opinion Desk Corroboration: 1 independent outlet South Korean biotech L&C Bio has developed an injectable treatment from donated human fat to restore facial volume lost due to weight-loss drugs like Ozempic. CEO Lee Whan Chul says the product, tentatively named MegaAdipoECM, acts as a scaffold for the patient's own fat cells. The company holds patents in South Korea, the US and China. Commercialisation was blocked because South Korean law classified donated fat as medical waste. Parliament legalised reuse this year, and L&C Bio expects to launch after a one-year grace period, likely in late 2027. Bloomberg reports the company had considered manufacturing in Singapore or the US. Critics argue the technology could divert resources from burn victims, but Lee says donors consent to cosmetic use and supports stronger regulation. ## Coverage - businesstoday.in Tags: biotech, cosmetic treatment, donated fat, Ozempic face, South Korea, weight-loss drugs Canonical: https://indianopinion.org/lc-bio-develops-fat-injection-to-treat-ozempic-face/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/lc-bio-develops-fat-injection-to-treat-ozempic-face/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.